Patients with AL amyloidosis treated with VAD followed by high dose melphalan and autologous stem cell transplantation

被引：0
|
作者：
van Gameren, II
Hazenberg, BPC
Jager, PL
Smit, JW
Vellenga, E
机构：
[1] Univ Groningen Hosp, Dept Rheumatol, Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Nucl Med, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Lab Med, Groningen, Netherlands
[4] Univ Groningen Hosp, Dept Haematol, Groningen, Netherlands
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Patients with AL amyloidosis treated with VAD followed by high dose melphalan and autologous stem cell transplantation
    van Gemeren, II
    Hazenberg, BPC
    Jager, PL
    Smit, JW
    Vellenga, E
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S122 - S122
  • [2] AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation
    van Gameren, II
    Hazenberg, BPC
    Jager, PL
    Smit, JW
    Vellenga, E
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2002, 9 (03): : 165 - 174
  • [3] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [4] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [5] Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation
    Gono, T
    Matsuda, M
    Dohi, N
    Hoshi, K
    Tada, T
    Sakashita, K
    Koike, K
    Aizawa, M
    Ikeda, S
    INTERNAL MEDICINE, 2003, 42 (01) : 72 - 77
  • [6] Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
    Seldin, DC
    Anderson, JJ
    Sanchorawala, V
    Malek, K
    Wright, DG
    Quillen, K
    Finn, KT
    Berk, JL
    Dember, LM
    Falk, RH
    Skinner, M
    BLOOD, 2004, 104 (06) : 1888 - 1893
  • [7] Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
    Osamu Yamazaki
    Yoshifumi Ubara
    Tatsuya Suwabe
    Shohei Nakanishi
    Junichi Hoshino
    Naoki Sawa
    Noriko Hayami
    Masayuki Yamanouchi
    Fumi Takemoto
    Takaichi Kenmei
    Kazuhiro Masuoka
    Kenichi Oohashi
    Clinical and Experimental Nephrology, 2009, 13 : 522 - 525
  • [8] High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis
    Perz, JB
    Schoenland, S
    Hundemer, M
    Linke, RP
    Ho, AD
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S159 - S159
  • [9] High Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 1131 - +
  • [10] Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
    Yamazaki, Osamu
    Ubara, Yoshifumi
    Suwabe, Tatsuya
    Nakanishi, Shohei
    Hoshino, Junichi
    Sawa, Naoki
    Hayami, Noriko
    Yamanouchi, Masayuki
    Takemoto, Fumi
    Kenmei, Takaichi
    Masuoka, Kazuhiro
    Oohashi, Kenichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (05) : 522 - 525
12345